Targeting Cardiac Fibrosis With a Vaccine Against Fibroblast Activation Protein

Overview

Journal Circ Res

Specialty Cardiology & Vascular Diseases

Date 2025 Jan 2

PMID 39745992

Authors

William M Oldham

Affiliations

Soon will be listed here.

References

Tillmanns J, Hoffmann D, Habbaba Y, Schmitto J, Sedding D, Fraccarollo D . Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarction. J Mol Cell Cardiol. 2015; 87:194-203. DOI: 10.1016/j.yjmcc.2015.08.016. View

Matsiukevich D, Kovacs A, Li T, Kokkonen-Simon K, Matkovich S, Oladipupo S . Characterization of a robust mouse model of heart failure with preserved ejection fraction. Am J Physiol Heart Circ Physiol. 2023; 325(2):H203-H231. DOI: 10.1152/ajpheart.00038.2023. View

Rurik J, Tombacz I, Yadegari A, Mendez Fernandez P, Shewale S, Li L . CAR T cells produced in vivo to treat cardiac injury. Science. 2022; 375(6576):91-96. PMC: 9983611. DOI: 10.1126/science.abm0594. View

Kaur H, Takefuji M, Ngai C, Carvalho J, Bayer J, Wietelmann A . Targeted Ablation of Periostin-Expressing Activated Fibroblasts Prevents Adverse Cardiac Remodeling in Mice. Circ Res. 2016; 118(12):1906-17. DOI: 10.1161/CIRCRESAHA.116.308643. View

Frangogiannis N . Cardiac fibrosis. Cardiovasc Res. 2020; 117(6):1450-1488. PMC: 8152700. DOI: 10.1093/cvr/cvaa324. View

Brudno J, Kochenderfer J . Current understanding and management of CAR T cell-associated toxicities. Nat Rev Clin Oncol. 2024; 21(7):501-521. PMC: 11529341. DOI: 10.1038/s41571-024-00903-0. View

Kimura T, Monslow J, Klampatsa A, Leibowitz M, Sun J, Liousia M . Loss of cells expressing fibroblast activation protein has variable effects in models of TGF-β and chronic bleomycin-induced fibrosis. Am J Physiol Lung Cell Mol Physiol. 2019; 317(2):L271-L282. DOI: 10.1152/ajplung.00071.2019. View

Amini L, Silbert S, Maude S, Nastoupil L, Ramos C, Brentjens R . Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion. Nat Rev Clin Oncol. 2022; 19(5):342-355. DOI: 10.1038/s41571-022-00607-3. View

Lee J, Byun J, Shim G, Oh Y . Fibroblast activation protein activated antifibrotic peptide delivery attenuates fibrosis in mouse models of liver fibrosis. Nat Commun. 2022; 13(1):1516. PMC: 8938482. DOI: 10.1038/s41467-022-29186-8. View

10.

Yoshida S, Hayashi H, Kawahara T, Katsuki S, Kimura M, Hino R . A Vaccine Against Fibroblast Activation Protein Improves Murine Cardiac Fibrosis by Preventing the Accumulation of Myofibroblasts. Circ Res. 2024; 136(1):26-40. PMC: 11692786. DOI: 10.1161/CIRCRESAHA.124.325017. View

11.

Aghajanian H, Kimura T, Rurik J, Hancock A, Leibowitz M, Li L . Targeting cardiac fibrosis with engineered T cells. Nature. 2019; 573(7774):430-433. PMC: 6752964. DOI: 10.1038/s41586-019-1546-z. View

12.

Rettig W, Garin-Chesa P, Beresford H, Oettgen H, Melamed M, Old L . Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells. Proc Natl Acad Sci U S A. 1988; 85(9):3110-4. PMC: 280153. DOI: 10.1073/pnas.85.9.3110. View

13.

Gonzalez A, Schelbert E, Diez J, Butler J . Myocardial Interstitial Fibrosis in Heart Failure: Biological and Translational Perspectives. J Am Coll Cardiol. 2018; 71(15):1696-1706. DOI: 10.1016/j.jacc.2018.02.021. View

14.

Ai K, Liu B, Chen X, Huang C, Yang L, Zhang W . Optimizing CAR-T cell therapy for solid tumors: current challenges and potential strategies. J Hematol Oncol. 2024; 17(1):105. PMC: 11539560. DOI: 10.1186/s13045-024-01625-7. View

15.

Kanisicak O, Khalil H, Ivey M, Karch J, Maliken B, Correll R . Genetic lineage tracing defines myofibroblast origin and function in the injured heart. Nat Commun. 2016; 7:12260. PMC: 5512625. DOI: 10.1038/ncomms12260. View